The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

January 30, 2023

Study Completion Date

March 1, 2023

Conditions

Adrenocortical Carcinoma

Interventions

DRUG

Mitotane

Individuals within the intervention group were on mitotane therapy as part of their ACC treatment.

Trial Locations (1)

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors

lead

King's College Hospital NHS Trust

OTHER